Patents by Inventor Lodewijk Ivo Caers

Lodewijk Ivo Caers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230089113
    Abstract: The present invention is directed to methods and dosing regimens for the treatment of depression (preferably, treatment resistant depression), for the treatment of depression in a suicidal patient, and/or for the treatment and/or prevention of suicidality (e.g. suicidal ideations).
    Type: Application
    Filed: April 22, 2022
    Publication date: March 23, 2023
    Inventors: Lodewijk Ivo Caers, Jaskaran Singh, Peter Nicholas Zannikos, Wayne C. Drevets, Ella Daly, Carla Maria Canuso, Margaret Fedgchin, Frank Wiegand, Giacomo Salvadore
  • Patent number: 11311500
    Abstract: The present invention is directed to methods and dosing regimens for the treatment of depression (preferably, treatment resistant depression), for the treatment of depression in a suicidal patient, and/or for the treatment and/or prevention of suicidality (e.g. suicidal ideations).
    Type: Grant
    Filed: June 11, 2021
    Date of Patent: April 26, 2022
    Assignee: Janssen Pharmaceutica NV
    Inventors: Lodewijk Ivo Caers, Jaskaran Singh, Peter Nicholas Zannikos, Wayne C. Drevets, Ella Daly, Carla Marie Canuso, Margaret Fedgchin, Frank Wiegand
  • Patent number: 11173134
    Abstract: The present invention is directed to methods and dosing regimens for the treatment of depression (preferably, treatment resistant depression), for the treatment of depression in a suicidal patient, and/or for the treatment and/or prevention of suicidality (e.g. suicidal ideations).
    Type: Grant
    Filed: December 21, 2020
    Date of Patent: November 16, 2021
    Assignee: Janssen Pharmaceutica NV
    Inventors: Lodewijk Ivo Caers, Jaskaran Singh, Peter Nicholas Zannikos, Wayne C. Drevets, Ella Daly, Carla Marie Canuso, Margaret Fedgchin, Frank Wiegand
  • Publication number: 20210308076
    Abstract: The present invention is directed to methods and dosing regimens for the treatment of depression (preferably, treatment resistant depression), for the treatment of depression in a suicidal patient, and/or for the treatment and/or prevention of suicidality (e.g. suicidal ideations).
    Type: Application
    Filed: June 11, 2021
    Publication date: October 7, 2021
    Inventors: Lodewijk Ivo Caers, Jaskaran Singh, Peter Nicholas Zannikos, Wayne C. Drevets, Ella Daly, Carla Marie Canuso, Margaret Fedgchin, Frank Wiegand
  • Publication number: 20210106545
    Abstract: The present invention is directed to methods and dosing regimens for the treatment of depression (preferably, treatment resistant depression), for the treatment of depression in a suicidal patient, and/or for the treatment and/or prevention of suicidality (e.g. suicidal ideations).
    Type: Application
    Filed: December 21, 2020
    Publication date: April 15, 2021
    Inventors: Lodewijk Ivo Caers, Jaskaran Singh, Peter Nicholas Zannikos, Wayne C. Drevets, Ella Daly, Carla Marie Canuso, Margaret Fedgchin, Frank Wiegand
  • Patent number: 10869844
    Abstract: The present invention is directed to methods and dosing regimens for the treatment of depression (preferably, treatment resistant depression), for the treatment of depression in a suicidal patient, and/or for the treatment and/or prevention of suicidality (e.g. suicidal ideations).
    Type: Grant
    Filed: December 26, 2019
    Date of Patent: December 22, 2020
    Assignee: Janssen Pharmaceutica NV
    Inventors: Lodewijk Ivo Caers, Jaskaran Singh, Peter Nicholas Zannikos, Wayne C. Drevets, Ella Daly, Carla Marie Canuso, Margaret Fedgchin, Frank Wiegand
  • Publication number: 20200246279
    Abstract: The present invention is directed to methods and dosing regimens for the treatment of depression (preferably, treatment resistant depression), for the treatment of depression in a suicidal patient, and/or for the treatment and/or prevention of suicidality (e.g. suicidal ideations).
    Type: Application
    Filed: December 26, 2019
    Publication date: August 6, 2020
    Inventors: Lodewijk Ivo Caers, Giacomo Salvadore, Jaskaran Singh
  • Publication number: 20160074340
    Abstract: The present invention is directed to methods and dosing regimens for the treatment of depression (preferably, treatment resistant depression), for the treatment of depression in a suicidal patient, and/or for the treatment and/or prevention of suicidality (e.g. suicidal ideations) comprising genotyping a patient to determine their Val66Met rs6265 polymorphism in BDNF and administering a ketamine, preferably esketamine, preferably intranasal esketamine, according to a dosing regimen matched to the patient's genotype.
    Type: Application
    Filed: September 14, 2015
    Publication date: March 17, 2016
    Applicant: JANSSEN PHARMACEUTICA NV
    Inventors: LODEWIJK IVO CAERS, GIACOMO SALVADORE, JASKARAN SINGH
  • Publication number: 20140093592
    Abstract: The present invention is directed to methods for the treatment of treatment-refractory depression or treatment-resistant depression comprising administering to a patient in need thereof, a therapeutically effective amount of esketamine as mono-therapy or as combination therapy with at least on antidepressant.
    Type: Application
    Filed: December 5, 2013
    Publication date: April 3, 2014
    Applicant: Janssen Pharmaceutica NV
    Inventors: Jaskaran Singh, Lodewijk Ivo Caers